Literature DB >> 20516477

EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.

Roi Avraham1, Aldema Sas-Chen, Ohad Manor, Israel Steinfeld, Reut Shalgi, Gabi Tarcic, Noa Bossel, Amit Zeisel, Ido Amit, Yaara Zwang, Espen Enerly, Hege G Russnes, Francesca Biagioni, Marcella Mottolese, Sabrina Strano, Giovanni Blandino, Anne-Lise Børresen-Dale, Yitzhak Pilpel, Zohar Yakhini, Eran Segal, Yosef Yarden.   

Abstract

Epidermal growth factor (EGF) stimulates cells by launching gene expression programs that are frequently deregulated in cancer. MicroRNAs, which attenuate gene expression by binding complementary regions in messenger RNAs, are broadly implicated in cancer. Using genome-wide approaches, we showed that EGF stimulation initiates a coordinated transcriptional program of microRNAs and transcription factors. The earliest event involved a decrease in the abundance of a subset of 23 microRNAs. This step permitted rapid induction of oncogenic transcription factors, such as c-FOS, encoded by immediate early genes. In line with roles as suppressors of EGF receptor (EGFR) signaling, we report that the abundance of this early subset of microRNAs is decreased in breast and in brain tumors driven by the EGFR or the closely related HER2. These findings identify specific microRNAs as attenuators of growth factor signaling and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516477     DOI: 10.1126/scisignal.2000876

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  62 in total

1.  A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.

Authors:  Aldema Sas-Chen; Roi Avraham; Yosef Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-12       Impact factor: 2.673

2.  A Network of Noncoding Regulatory RNAs Acts in the Mammalian Brain.

Authors:  Benjamin Kleaveland; Charlie Y Shi; Joanna Stefano; David P Bartel
Journal:  Cell       Date:  2018-06-07       Impact factor: 41.582

3.  Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.

Authors:  Qiang Zhao; Jun Cao; Yi-Chen Wu; Xiang Liu; Jing Han; Xian-Cong Huang; Lie-Hao Jiang; Xiu-Xiu Hou; Wei-Min Mao; Zhi-Qiang Ling
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

4.  EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.

Authors:  Hongyan Zhu; Urszula Dougherty; Victoria Robinson; Reba Mustafi; Joel Pekow; Sonia Kupfer; Yan Chun Li; John Hart; Kathleen Goss; Alessandro Fichera; Loren Joseph; Marc Bissonnette
Journal:  Mol Cancer Res       Date:  2011-06-08       Impact factor: 5.852

5.  RNA-mediated degradation of microRNAs: A widespread viral strategy?

Authors:  Jana McCaskill; Pairoa Praihirunkit; Paul M Sharp; Amy H Buck
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

6.  ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.

Authors:  Nir Ben-Chetrit; Gabi Tarcic; Yosef Yarden
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 7.  Regulation of signalling by microRNAs.

Authors:  Roi Avraham; Yosef Yarden
Journal:  Biochem Soc Trans       Date:  2012-02       Impact factor: 5.407

Review 8.  Regulation of primary response genes.

Authors:  Trent Fowler; Ranjan Sen; Ananda L Roy
Journal:  Mol Cell       Date:  2011-11-04       Impact factor: 17.970

9.  Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue.

Authors:  Eldrid Borgan; Roy Navon; Hans Kristian Moen Vollan; Ellen Schlichting; Torill Sauer; Zohar Yakhini; Ole Christian Lingjærde; Therese Sørlie; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2011-08-29       Impact factor: 6.603

10.  Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.

Authors:  German G Gomez; Stefano Volinia; Carlo M Croce; Ciro Zanca; Ming Li; Ryan Emnett; David H Gutmann; Cameron W Brennan; Frank B Furnari; Webster K Cavenee
Journal:  Cancer Res       Date:  2014-01-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.